See All Slides - tctmd.com

Slides

Presentation TCT 2012

CAS Decision Making in Women

Presenter: Isabelle Van Herzeele

October 22, 2012

Presentation TCT 2012

Safety of the Stop-flow Intracoronary Technique: Single-center Experience

Presenter: Andreas Zeiher

October 22, 2012

Presentation TCT 2012

Retrograde Application of Autologous BM Cells: Phase 2 Study Results

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

Presenter: Elvin Kedhi

October 22, 2012

Presentation TCT 2012

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Presenter: Todd Dewey

October 22, 2012

Presentation TCT 2012

Case Presentation(3)

Presenter: Joachim Schofer

October 22, 2012

Presentation TCT 2012

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Presenter: Michael Reardon

October 22, 2012

Presentation TCT 2012

Provisional Stenting Technique: Step by Step Tutorial (Including Crossover Techniques)

Presenter: Yves Louvard

October 22, 2012

Presentation TCT 2012

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Advertisement

Slides

CAS Decision Making in Women

Safety of the Stop-flow Intracoronary Technique: Single-center Experience

Retrograde Application of Autologous BM Cells: Phase 2 Study Results

Do Patient and Stent Platform Specific Variables Matter (e.g. ACS vs. Stable CAD, First vs. Second Generation DES)?

New Data from PARTNER Continued Access (Non-randomized): Transapical Outcomes After TAVR

Case Presentation(3)

“Direct” Aortic Access is Easier, Safer, and Should be the Preferred Access Alternative!

Provisional Stenting Technique: Step by Step Tutorial (Including Crossover Techniques)

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content